Mucosal immunity induced by parenteral immunization with a live attenuated Venezuelan equine encephalitis virus vaccine candidate

Virology

Volumn 228, Issue 2, 1997, Pages 153-160

  Charles, Peter C ^a   Brown, Kevin W ^a   Davis, Nancy L ^a   Hart, Mary Kate ^b   Johnston, Robert E ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b Dept of Immunol and Molec Biology Bldg 1425 U States Army Med R   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIVE VACCINE; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; IMMUNIZATION; MOUSE; MUCOSA; NONHUMAN; PRIORITY JOURNAL; VAGINA; VENEZUELAN EQUINE ENCEPHALOMYELITIS ALPHAVIRUS; VIRUS ATTENUATION;

ALPHAVIRUS; ANIMALIA; EQUIDAE; VENEZUELAN EQUINE ENCEPHALITIS VIRUS;

EID: 0031575538     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1996.8381     Document Type: Article

References (25)

1. Charles P. C., Walters E., Margolis R., Johnston R. E. Mechanism of neuroinvasion of Venezuelan equine encephalitis virus in the mouse. Virology. 208:1995;662-671.
2. Davis N. L., Willis L. V., Smith J. F., Johnston R. E. In vitro synthesis of infectious venezuelan equine encephalitis virus RNA from a cDNA clone: Analysis of a viable deletion mutant. Virology. 171:1989;189-204.
3. Davis N. L. Attenuating mutations in the E2 glycoprotein gene of Venezuelan equine encephalitis virus: Construction of single and multiple mutants in a full-length cDNA clone. Virology. 183:1991;20-31.
4. Davis N. L. Attenuated mutants of Venezuelan equine encephalitis virus containing lethal mutations in the PE2 cleavage signal combined with a second-site suppressor mutation in E1. Virology. 212:1995;102-110.
5. Davis N. L., Brown K. W., Johnston R. E. A viral vaccine vector that expresses foreign genes in lymph nodes and protects against mucosal challenge. J. Virol. 70:1996;3781-3787.
6. Gorelkin L., Jahrling P. B. Virus-initiated septic shock. Acute death of Venezuelan encephalitis virus-infected hamsters. Lab. Invest. 32:1975;78-85.
7. Grieder F. B. Specific restrictions in the progression of Venezuelan equine encephalitis virus-induced disease resulting from single amino acid changes in the glycoproteins. Virology. 206:1995;994-1006.
8. Holmgren J. Mucosal immunity and vaccination. FEMS Microbiol. Immunol. 89:1991;1-9.
9. Jahrling P. B., Stephenson E. H. Protective efficacies of live attenuated and formaldehyde-inactivated Venezuelan equine encephalitis virus vaccines against aerosol challenge in hamsters. J. Clin. Microbiol. 19:1984;429-431.
10. Johnston R. E., Smith J. F. Selection for accelerated penetration in cell culture coselects for attenuated mutants of Venezuelan equine encephalitis virus. Virology. 162:1988;437-443.
11. Kinney R. M. Recombinant vaccinia virus/Venezuelan equine encephalitis (VEE) virus protects mice from peripheral VEE virus challenge. J. Virol. 62:1988;4697-4702.
12. Lange S., Nygren H., Svennerholm A.-M., Holmgren J. Antitoxic cholera immunity in mice: Influence of antigen deposition on antitoxin-containing cells and protective immunity in different parts of the intestine. Infect. Immun. 28:1980;17-23.
13. Liang X., Lamm M. E., Nedrud J. G. Oral administration of cholera toxin-Sendai virus conjugate potentiates gut and respiratory immunity against Sendai virus. J. Immunol. 141:1988;1495-1501.
14. Meitin C. A., Bender B. S., Small P. A. Jr. Influenza immunization: Intranasal live vaccinia recombinant contrasted with parenteral inactivated vaccine. Vaccine. 9:1991;751-756.
15. Meitin C. A., Bender B. S., Small P. A. Jr. Enteric immunization of mice against influenza with recombinant vaccinia. Proc. Natl. Acad. Sci. USA. 91:1994;11187-11191.
16. Nedrud J. G., Liang X., Hague N., Lamm M. E. Combined oral/nasal immunization protects mice from Sendai virus infection. J. Immunol. 139:1987;3484-3492.
17. Olmsted R. A., Meyer W. J., Johnston R. E. Characterization of Sindbis virus epitopes important for penetration in cell culture and pathogenesis in animals. Virology. 148:1986;245-254.
18. Peters C. J., Dalrymple M. J. The alphaviruses. Virology. 1990;Raven Press, New York. p. 713-761.
19. Rhyzikov A. B., Tkacheva N. V., Sergeev A. N., Ryabchikova E. I. Venezuelan equine encephalitis virus propagation in the olfactory tract of normal and immunized mice. Biomed. Sci. 2:1991;607-614.
20. Ryzhikov A. B., Ryabchikova E. I., Sergeev A. N., Tkacheva N. V. Spread of Venezuelan equine encephalitis virus in mice olfactory tract. Arch. Virol. 140:1995;2243-2254.
21. Svennerholm A. M. Different secretory immunoglobulin A antibody responses to cholera vaccination in Swedish and Pakistani women. Infect. Immun. 30:1980;427-430.
22. Turrel M. J., Spielman A. Nonvascular delivery of Rift Valley fever virus by infected mosquitoes. Am. J. Trop. Med. Hyg. 47:1992;190-194.
23. Turrel M. J., Tammariello R. F., Spielman A. Nonvascular delivery of St. Louis encephalitis and Venezuelan equine encephalitis viruses by infected mosquitoes (Diptera: Culicidae) feeding on a vertebrate host. J. Med. Entomol. 32:1995;563-568.
24. Weisz-Carrington P., Grimes S. R. Jr., Lamm M. E. Gut-associated lymphoid tissue as source of an IgA immune response in respiratory tissues after oral immunization and intrabronchial challenge. Cell. Immunol. 106:1987;132-138.
25. Weisz-Carrington P., Roux M. E., McWilliams M., Phillips-Quagliata J. M., Lamm M. E. Organ and isotype distribution of plasma cells producing specific antibody after oral immunization: Evidence for a generalized secretory immune system. J. Immunol. 123:1979;1705-1708.